Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF- dependent growth of human glioblastoma tumor cells

Cancer Research

Volumn 56, Issue 22, 1996, Pages 5156-5164

  Aggarwal, Bharat B ^a   Schwarz, Lindsay ^b,d   Hogan, Michael E ^b   Rando, Robert F ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Antigenics Inc   (United States)

^d UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NUCLEASE; OLIGODEOXYRIBONUCLEOTIDE; RECOMBINANT TUMOR NECROSIS FACTOR; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; CELL PROLIFERATION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIORECEPTOR ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIPLE HELIX; TUMOR GROWTH;

ANIMALS; BASE SEQUENCE; BIOLOGICAL ASSAY; CELL DIVISION; DRUG DESIGN; GLIOBLASTOMA; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029824946     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Weintraub, H M. Antisense RNA and DNA. Sci. Am, 262: 40-46, 1990.
2. Cohen, J. S. Designing antisense oligonucleotides as pharmaceutical agents. Trends Biochem. Sci, 10: 435-437, 1989.
3. Calabretta, B Inhibition of proto-oncogene expression by antisense oligodeoxynucleotides biological and therapeutic implications Cancer Res., 51, 4505-4510, 1991.
4. Riordan, M. L, and Martin, J C Oligonucleotide-based therapeutics. Nature (Lond), 350: 442-443, 1991.
5. Carter, G, and Lemoine, N R Antisense technology for cancer therapy: does it make sense? Br J Cancer, 67, 869-876, 1993
6. Stein, C. A, and Cheng, Y C. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science (Washington DC), 261: 1004-1012, 1993.
7. Agrawal, S., Ikeuchi, T , Sun, D, Sarin, P. S., Konopka, A., Maizel, J, and Zamecnik, P C. Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues Proc. Natl. Acad. Sci. USA, 86: 7790-7794, 1989
8. Wickstrom, E L, Bacon, T. A., Gonzalez, A., Freeman, D. L., Lyman, G. H, and Wickstrom, E. Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc. Natl. Acad Sci USA, 85: 1028-1032, 1988.
9. Morrison, R. S. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J. Biol. Chem., 266: 728-734, 1991.
10. Durland, R H, Kessler, D J, Gunnell, S., Duvic, M., Pettitt, B. M., and Hogan, M. D. Binding of triple helix forming oligonucleotides to sites in gene promoters. Biochemistry, 30: 9246-9255, 1991.
11. Grigoriev, M, Praseuth, D, Guieysse, A. L., Robin, P., Thuong, N. T., Helene, C., and Harel-Bellan, A. Inhibition of gene expression by triple helix-directed DNA cross-linking at specific sites. Proc Natl. Acad Sci. USA. 90: 3501-3505, 1993
12. Bock, L. C., Griffin, L. C., Latham, J A., Vermaas, E. H., and Toole, J J Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature (Lond), 355: 564-566, 1992.
13. Paborsky, L R, McCurdy, S. N, Griffin, L. C., Toole, J. J., and Leung, L. L K. The single-stranded DNA aptamer-binding site of human thrombin. J. Biol. Chem., 268: 20808-20811, 1993.
14. Postel, E. H., Flint, S. J., Kessler, D. J., and Hogan, M E Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels. Proc Natl. Acad. Sci. USA, 88: 8227-8231, 1991.
15. McShan, W. M., Rossen, R. D, Laughter, A H, Trial, J, Kessler, D J, Zendegui, J. G., Hogan, M. E, and Orson, F. M. Inhibition of transcription of HIV-1 infected human cells by oligodeoxynucleotides designed to form DNA triple helices J Biol. Chem, 267: 5712-5721, 1992.
16. Orson, F. M, Thomas, D. W., McShan, W. M., Kessler, D J., and Hogan, M. E. Oligonucleotide inhibition of IL2RI mRNA transcription by promoter region collinear triplex formation in lymphocytes. Nucleic Acids Res, 19: 3435-3441, 1991.
17. Grigoriev, M, Praseuth, D., Robin, P., Hemar, A., Saison-Behmoaras, T., Dautry-Varsat, A., Thuong, N T., Helene, C, and Harel-Bellan, A A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF RB binding to interleukin-2 receptor I-regulatory sequence. J. Biol. Chem., 267: 3389-3395, 1992
18. Ing, N. H., Beekman, J. M, Kessler, D. J., Murphy, M., Jayaraman, K., Zendegui, J. G, Hogan, M. E., O'Malley, B. W., and Tsai, M. J. In vivo transcription of a progesterone-responsive gene is specifically inhibited by a triplex-forming oligonucleotide. Nucleic Acids Res., 21: 2789-2796, 1993
19. Aggarwal, B. B, Kohr, W J, Hass, P. E, Moffat, B, Spencer, S A, Henzel, W J., Bringman, T. S., Nedwin, G. E, Goeddel, D V., and Harkins, R. N Human tumor necrosis factor production, purification and characterization J. Biol. Chem., 260: 2345-2354, 1985.
20. Pennica, D., Nedwin, G. E., Hayflick, J F., Seeburg, P. H, Palladino, M. A., Kohr, W. J., Aggarwal, B. B., and Goeddel, D. V Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature (Lond.), 312: 724-729, 1984
21. Aiyer, R. A., and Aggarwal, B B. Tumor necrosis factors. In: E R. Podack (ed.), CRC Handbook on Cytolytic Lymphocytes and Complement: Effectors of the Immune System, pp 105-132. Boca Raton, FL CRC Press, Inc., 1988.
22. Goeddel, D. V., Aggarwal, B. B., Gray, P W., Leung, D. W., Nedwin, G. E., Palladino, M. A., Patton, J S., Pennica, D., Shepard, H. M, Sugarman, B. J., and Wong, G. H. W. Tumor necrosis factors, gene structure and biological activities. Cold Spring Harbor Symp. Quant. Biol, L1 597-609, 1986.
23. Aggarwal, B. B., and Vilcek, J Tumor Necrosis Factor: Structure, Function and Mechanism of Action. pp. I-624. New York: Marcel Dekker, Inc, 1992.
24. Duncombe, A. S, Heslop, H. E., Turner, M, Meager, A., Priest, R, Exley, T, and Brenner, M. K. Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia. J. Immunol., 143 3828-3834, 1989
25. Miura, K., Teramura, M., Hoshino, S, Mizoguchi, H., and Sato, T Stimulatory effect of tumor necrosis factor-I on the growth of CMK, a human megakaryoblastic leukemia cell line. Leuk. Res., 16: 281-285, 1992
26. Wu, S., Boyer, C. M, Whitaker, R S., Berchuck, A, Wiener, J R, Weinberg, J B., and Bast, R. C., Jr. Tumor necrosis factor I as an autocrine and paracrine growth factor for ovarian cancer monokine induction of tumor cell proliferation and tumor necrosis factor I expression Cancer Res, 53 1939-1944, 1993.
27. Goillot, E, Combaret, V., Ladenstein, R, Baubet, D., Blay, J. Y, Philip, T, and Favrot, M. C. Tumor necrosis factor as an autocrine growth factor for neuroblastoma. Cancer Res., 52: 3194-3200, 1992
28. Lachman, L B, Brown, D. C., and Dinarello, C. A. Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line J. Immunol., 138: 2913-2916, 1987
29. Ojwang, J, Elbaggari, A., Marshall, H B, Jayaraman, K , McGrath, M. S., and Rando, R F Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine J Acquired Immune Defic. Syndr, 7: 560-570, 1994.
30. Rando, R. F, Ojwang, J, Elbaggari, A, Reyes, G. R, Tinder, R, McGrath, M. S, and Hogan, M. E. Suppression of human immunodeficiency type 1 activity in vitro by oligonucleotides which form intramolecular tetrads. J. Biol Chem., 270: 1754-1760, 1995.
31. Zendegui, J. G., Vasquez, K. M., Tinsley, J. H., Kessler, D. J, and Hogan, M. E. In vivo stability and kinetics of absorption and disposition of 3′ phosphopropyl amine oligonucleotides. Nucleic Acids Res., 20: 307-314, 1992.
32. Birg, F, Praseuth, D., Zerial, A., Thuong, N. T., Asseline, U., LeDoan, T., and Helen, C. Inhibition of simian virus 40 DNA replication in CV-1 cells by oligodeoxynucleotide covalently linked to an intercalating agent. Nucleic Acids Res., 18: 2901-2908, 1990
33. Nelson, P. S., Frye, R. A., and Liu, E Bifunctional oligonucleotide probes synthesized using a novel CPG support are able to detect single base pair mutations. Nucleic Acids Res, 17: 7187-7191, 1989.
34. Vu, H, Singh, P, Lewis, L., Zendegui, J. G., and Jayaraman, K. Synthesis of Cholesteryl supports and phosphoramidites for automated DNA synthesis of triple-helix forming oligonucleotides (TFOs). Nucleosides & Nucleotides, 12: 853-864, 1993.
35. Vu, H., and Hirschbein, B L Internucleotide phosphite sulfurization with tetraethylthiuram disulfide: phosphorothioate oligonucleotide synthesis via phosphoramidite chemistry Tetrahedron Lett., 32: 3005-3008, 1991
36. Ojwang, J., Okleberry, K. M., Marshall, H B., Vu, H. M., Huffman, J. H., and Rando, R. F. Inhibition of friend murine leukemia virus activity by guanosine/thymidine oligonucleotides. Antiviral Res , 25: 27-41, 1994.
37. Sugarman, B J., Aggarwal, B B., Hass, P. E., Figari, I. S., Palladino, M. A., and Shepard, H. M. Recombinant human tumor necrosis factor-I: effects on proliferation of normal and transformed cells in vitro. Science (Washington DC), 230: 943-945, 1985.
38. Hudziak, R. M., Lewis, G. D., Eessalu, T. E., Aggarwal, B. B., Ullrich, A., and Shepard, H. M. Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor-I in NIH 3T3 cells Proc. Natl. Acad Sci. USA, 85: 5102-5106, 1988.
39. Baltuch, G. H., Couldwell, W. T., Villemure, J-G, and Yong, V. W. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines: a comparison between staurosporine and tamoxifen Neurosurgery, 33 495-501, 1993.
40. Vilcek, J., Palombella, V. J, Henriksen-DeStefano, D., Swenson, C., Feinman, R., Hirai, M, and Tsujimoto, M. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J. Exp. Med, 163 632-643, 1986
41. Aggarwal, B. B., Eessalu, T E., and Hass, P. E Characterization of receptors for human tumor necrosis factor and their regulation by K-interferon. Nature (Lond.), 318: 665-667, 1985.
42. Higuchi, M., and Aggarwal, B. B. Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant p60 and p80 receptors Biochem. Biophys. Res. Commun., 182 638-643, 1992.
43. Brenner, C. A., Tam, A. W., Nelson, P. A., Engleman, E. G, Suzuki, N., Fry, K E., and Larrick, J W. Message amplification phenotyping (MAPPING): a technique to simultaneously measure multiple mRNA from small numbers of cells. Biotechniques, 7: 1096, 1989.
44. Chomczynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction Anal. Biochem., 162: 156-159, 1987.
45. Rappolee, D. A., Wang, A., Mark, D., and Werb, Z Novel method for studying mRNA phenotypes in single or small numbers of cells. J. Cell. Biochem., 39 1-11, 1989.
46. Nedwin, G., Naylor, S. L., Sakaguchi, A. Y, Smith, D., Nedwin, G. E., Pennica, D., Goedell, D. V., and Gray, P. W. Human lymphotoxin and tumor necrosis factor genes. structure, homology and chromosome localization. Nucleic Acids Res., 13: 6361-6372, 1985.
47. Ebbinghaus, S. W., Gee, J E., Rodu, B, Mayfield, C. A., Sanders, G., and Miller, D. M. Triplex formation inhibits HER2/neu transcription in vitro. J. Clin Invest., 92: 2433-2439, 1993
48. Rando, R F., De Paolis, L., Durland, R. H., Jayaraman, K., Kessler, D. J., and Hogan, M. E. Inhibition of T7 and T3 RNA polymerase directed transcription elongation in vitro. Nucleic Acids Res , 22: 678-685, 1994